ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
9.30
-0.04 (-0.38%)
May 2, 2024, 1:15 PM EDT - Market open
ARS Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$18.50
Upside
+99.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $19 | Buy | Reiterates | $19 | +104.41% | Mar 11, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $6 → $18 | Hold → Buy | Upgrades | $6 → $18 | +93.65% | Mar 5, 2024 |
| Wedbush | Wedbush | Buy Maintains $5 → $13 | Buy | Maintains | $5 → $13 | +39.86% | Nov 13, 2023 |
| Wedbush | Wedbush | Buy Maintains $15 → $5 | Buy | Maintains | $15 → $5 | -46.21% | Sep 21, 2023 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 20, 2023 |
| Wedbush | Wedbush | Buy Reiterates $15 | Buy | Reiterates | $15 | +61.38% | Aug 14, 2023 |
| Wedbush | Wedbush | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +61.38% | Jun 21, 2023 |
| Wedbush | Wedbush | Buy Reiterates $17 | Buy | Reiterates | $17 | +82.89% | May 18, 2023 |
| Wedbush | Wedbush | Buy Reiterates $17 | Buy | Reiterates | $17 | +82.89% | May 12, 2023 |
| Wedbush | Wedbush | Buy Reiterates $17 | Buy | Reiterates | $17 | +82.89% | May 10, 2023 |
| Wedbush | Wedbush | Buy Initiates $10 | Buy | Initiates | $10 | +7.58% | Jan 31, 2023 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 4, 2023 |
| SVB Leerink | SVB Leerink | Buy Initiates $14 | Buy | Initiates | $14 | +50.62% | Dec 13, 2022 |